Telix Pharmaceuticals Limited
TLX
$17.60
$0.301.73%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 439.60M | 492.51M | 79.29M | 80.02M | 84.01M |
| Total Receivables | 92.51M | 103.64M | 59.60M | 54.20M | 49.00M |
| Inventory | 23.61M | 26.45M | 20.55M | 12.52M | 11.80M |
| Prepaid Expenses | 6.86M | 7.68M | -- | -- | 8.47M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.89M | 6.60M | 10.87M | 13.43M | 5.22M |
| Total Current Assets | 568.45M | 636.87M | 170.31M | 160.17M | 158.49M |
|
|
|||||
| Total Current Assets | 568.45M | 636.87M | 170.31M | 160.17M | 158.49M |
| Net Property, Plant & Equipment | 33.62M | 37.66M | 25.52M | 21.12M | 20.79M |
| Long-term Investments | 66.00M | 73.94M | 78.56M | 3.19M | 3.30M |
| Goodwill | 66.00M | 73.94M | 78.56M | 3.19M | 3.30M |
| Total Other Intangibles | 191.53M | 214.58M | 187.98M | 70.24M | 71.45M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 75.08M | 84.12M | 28.35M | 25.69M | 14.34M |
| Total Assets | 938.44M | 1.05B | 497.70M | 280.40M | 276.73M |
|
|
|||||
| Total Accounts Payable | 42.51M | 47.63M | 14.88M | 13.84M | 22.38M |
| Total Accrued Expenses | 47.89M | 53.65M | 46.61M | 34.00M | 38.20M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.30M | 14.90M | 2.52M | 1.38M | 1.06M |
| Total Finance Division Other Current Liabilities | 101.08M | 113.25M | 108.37M | 48.83M | 50.87M |
| Total Other Current Liabilities | 101.08M | 113.25M | 108.37M | 48.83M | 50.87M |
| Total Current Liabilities | 204.79M | 229.43M | 172.39M | 98.05M | 112.52M |
|
|
|||||
| Total Current Liabilities | 204.79M | 229.43M | 172.39M | 98.05M | 112.52M |
| Long-Term Debt | 341.49M | 382.60M | 6.64M | 6.56M | 5.60M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.04M | 5.64M | 5.61M | 4.51M | 5.23M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 35.49M | 39.76M | 43.53M | 53.14M | 51.87M |
| Total Liabilities | 586.80M | 657.43M | 228.17M | 162.26M | 175.22M |
|
|
|||||
| Common Stock & APIC | 369.31M | 413.77M | 391.92M | 293.36M | 304.20M |
| Retained Earnings | -131.79M | -147.65M | -155.79M | -160.07M | -179.73M |
| Treasury Stock & Other | 114.12M | 127.85M | 33.41M | -15.15M | -22.97M |
| Total Common Equity | 351.64M | 393.96M | 269.53M | 118.14M | 101.51M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 351.64M | 393.96M | 269.53M | 118.14M | 101.51M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 351.64M | 393.96M | 269.53M | 118.14M | 101.51M |
|
|
|||||
